Korvest Ltd (ASX:KOV) Announces Pause in Trading
Korvest Ltd (ASX:KOV) has temporarily paused trading of its securities pending a further announcement.
Korvest Ltd (ASX:KOV) has temporarily paused trading of its securities pending a further announcement.
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Integral Diagnostics receives ACCC clearance for its merger with Capitol Health, expecting implementation by 20 December 2024.
Capitol Health Limited receives ACCC clearance for its proposed merger with Integral Diagnostics, moving closer to final court approval.
Doctor Care Anywhere announces Laura O’Riordan as new CEO from January 2025, focusing on growth and quality in virtual healthcare.
Riedel Resources Limited announces successful completion of capital consolidation at 1 for 40 basis, reshaping its equity structure.
Integral Diagnostics secures ACCC approval for Capitol Health acquisition, requiring divestiture of a clinic in the Melton region.
LTR Pharma Limited secures A$25 million to advance its SPONTAN® treatment through regulatory processes in the U.S. market.
29Metals Limited (ASX:29M) launches a retail entitlement offer aiming to raise approximately $36.2 million as part of a $180 million capital raise.
Transurban Group (ASX:TCL) declares a 32.0-cent distribution and reaffirms its FY25 guidance amidst notable traffic growth.